Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Ammonia | HCID 222 | — |
| Edukt | Dimethyl Sulfone | HCID 6213 | — |
| Edukt | Sodium Hydroxide | HCID 14798 | — |
| Edukt | m-Chloroperbenzoic acid | HCID 70297 | — |
| Edukt | Bromotrimethylsilane | HCID 76113 | — |
| Edukt | 1,8-Diazabicyclo(5.4.0)undec-7-ene | HCID 81184 | — |
| Edukt | 4,6-Bis(methylthio)-1H-pyrazolo[3,4-d]pyrimidine | HCID 223695 | — |
| Edukt | Di-(2-propyl)-2-chloroethoxymethylphosphonate | HCID 10587339 | — |
| Katalysator | Palladium | HCID 23938 | — |
| Produkt | 1H-Pyrazolo(3,4-d)pyrimidine | HCID 67499 | — |
Reaktionsschritte
Di-(2-propyl)-2-chloroethoxymethylphosphonate is reacted with 4,6-bismethylmercapto-pyrazolo[3,4-d]pyrimidine (Tetrahedron, 1967, 23: 891) in the presence of DBU to effect attachment at the pyrazole ring nitrogen(s). Displacement of the 4-methymercapto functionality and concommitant monoester hydrolysis is then effected using aqueous sodium hydroxide. Displacement of the remaining 6-methymercapto group is accomplished (after initial oxidation with m-chloroperbenzoic acid to the intermediate methy sulfone) using methanolic ammonia. Bromination at the 3-position is performed according to the procedure described in J. Med. Chem. 1984, 27: 1026-30. Displacement of the 3-bromo group with Fmoc-protected propargylamine is effected using the palladium(0) catalyst described above. The remaining phosphate ester is then deprotected using bromotrimethylsilane. Pyrophosphorylation, deprotection and dye coupling are then performed as described above to yield the fluorescently labeled PME-G-pp analog (pyrazolo[3,4-d]pyrimidine analog).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US06858393B1 |
|---|
| Quelldatensatz | uspto-grants-2005_02 |
|---|
| ORD ID | ord-f651969384424f18a67bd67ddd5a9807 |
|---|
| Quellennotiz | uspto-grants-2005_02 |
|---|